Suchergebnisse - "Pearson, Steven D"

PubPharm (7)

1

Oral and monoclonal antibody treatments for relapsing forms of multiple sclerosis : Effectiveness and value

enthalten in: Journal of managed care & specialty pharmacy | 2023

von McKenna, A. | Lin, G. | Whittington, M. | +5

2

JAK inhibitors and monoclonal antibodies for the treatment of atopic dermatitis : effectiveness and value

enthalten in: Journal of managed care & specialty pharmacy | 2022

von Agboola, F. | Atlas, S. | Brouwer, E. | +6

3

Comparative effectiveness of targeted immunomodulators for the treatment of moderate-to-severe plaque psoriasis : A systematic review and network meta-analysis

enthalten in: Journal of the American Academy of Dermatology | 2018

von Loos, A. | Liu, S. | Segel, C. | +3

4

Cost-effectiveness of Drugs to Treat Relapsed/Refractory Multiple Myeloma in the United States

enthalten in: Journal of managed care & specialty pharmacy | 2018

von Carlson, J. | Guzauskas, G. | Chapman, R. | +6

CommentIn: J Manag Care Spec Pharm. 2018 Jul;24(7):712-713. - PMID 29952702

5

Cost-effectiveness of PCSK9 Inhibitor Therapy in Patients With Heterozygous Familial Hypercholesterolemia or Atherosclerotic Cardiovascular Disease

enthalten in: JAMA | 2016

von Kazi, D. | Moran, A. | Coxson, P. | +6

CommentIn: JAMA. 2016 Nov 22;316(20):2151-2152. - PMID 27893122

6

Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibitors for Treatment of High Cholesterol Levels : Effectiveness and Value

enthalten in: JAMA internal medicine | 2016

von Tice, J. | Kazi, D. | Pearson, S.

CommentIn: JAMA Intern Med. 2016 Jan;176(1):109. - PMID 26662340

7

Cost-related motivations for conducting research : participants should be informed

enthalten in: JAMA | 2014

von Nayak, R. | Pearson, S. | Miller, F.

ErratumIn: JAMA. 2014 Aug 27;312(8):848

1
[1]